The largest Insider Buys this week were in Salesforce.com Inc. (CRM, Financial), Lamb Weston Holdings Inc. (LW, Financial), Karuna Therapeutics Inc. (KRTX, Financial) and Compass Diversified Holdings (CODI, Financial).
Salesforce.com director bought 1,100 shares
Director Susan Wojcicki bought 1,100 shares on Jan. 7 for an average price of $175.26. The stock has gained 2.82% since then.
Salesforce is an American cloud computing company. Although most of its revenue comes from customer relationship management products, the company also capitalizes on commercial applications of social networking through acquisition. The company has a market capitalization of $159.84 billion; as of Jan. 10, it traded at $180.20.
On Dec. 12, Salesforce announced that President and Chief Product Officer Bret Taylor had been appointed president and chief operating officer. Taylor is the co-founder and former CEO of Quip, which was acquired by Salesforce in 2016. Before Quip, Taylor also served as the chief technology officer of Facebook. In his new position, Taylor will continue to report to chairman and co-CEO Marc Benioff.
Lamb Weston director bought 18,000 shares
Director William G. Jurgensen bought 18,000 shares on Jan. 8 for an average price of $92.01. The share price has risen 1.66% since then.
Lamb Weston is an American food processing company that is one of the world’s largest producers of frozen French fries and other frozen potato products. The company is a component of the S&P 500 and was spun off from Conagra Brands (CAG, Financial) in 2016. The company has a market capitalization of $13.22 billion; as of Jan. 10, it traded at $90.48.
On Jan. 3, Lamb Weston reported financial results for the second quarter of 2020. Net sales grew 12% to $1.019 billion from the prior-year quarter. Income from operations increased 11% to $194 million. Diluted earnings per share rose 28% to 95 cents from diluted earnings per share of 74 cents a year ago.
Karuna Therapeutics director bought 1,427 shares
Director Heather Preston bought 788 shares on Jan. 9 for an average price of $70.50. Since then, the share price has advanced 2.37%.
Karuna Therapeutics is an American clinical-stage biopharmaceutical company that is focused on developing new therapies for neuropsychiatric conditions with significant unmet medical needs. The company’s lead product is KarXT, a proprietary oral drug that combines xanomeline with trospium to stimulate muscarinic receptors in the central nervous system. The company has a market capitalization of $1.88 billion; as of Jan. 10, it traded at $72.17.
On Nov. 20, Karuna Therapeutics announced the pricing of the previously announced underwritten public offering of 2,600,000 shares of its common stock at a price of $96 per share. The gross proceeds were projected to total approximately $250 million. The offering closed on Nov.r 25.
Compass Diversified Holdings chairman bought 4,677 shares
Chairman Sean C. Daybought 4,677 shares on Jan. 3 for an average price of $25.58. The stock has decreased 2.85% since then.
Compass Diversified is an American industrial holdings company that focuses on the middle market space. The company maintains eight majority-owned subsidiaries that include Advanced Circuits, Arnold Magnetic Technologies and Ergobaby, among others. The company has a market capitalization of $1.49 billion; as of Jan. 10, it traded at $24.85.
On Jan. 6, Compass Diversified announced its board of directors declared a quarterly cash dividend of 36 cents per share. The dividend is payable on Jan. 23 to all shareholders of record at the close of business on Jan. 16.
For the complete list of stocks that were bought by their company executives, go to Insider Trades.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
